EXHIBIT 99.1
Amedisys
A Healthy Investment for the 21st Century
================================================================================
Statements contained in this presentation which are not historical facts are
forward-looking statements. These forward-looking statements and all other
statements that may be contained in this presentation that are not historical
facts are subject to a number of risks and uncertainties, and actual results may
differ materially than those forecasted. Such forward-looking statements are
estimates reflecting the best judgment of Amedisys, Inc. management based upon
currently available information. Certain factors which could affect the accuracy
of such forward-looking statements are identified in the public filings made by
Amedisys, Inc. with the Securities and Exchange Commission, and forward-looking
statements contained herein, or other public statements of Amedisys, Inc. or its
management should be considered in light of those factors.
================================================================================
Amedisys Facts
o One of the top 5 U.S. home nursing companies
o Profitable in Medicare's Prospective Payment System
o Provides skilled nursing care supported with acute care technology
o Publicly traded since 1994
================================================================================
Amedisys Facts
Largest Home Care Nursing Company in the South
60 Locations
Oklahoma - 5
Louisiana - 5
Alabama - 10
Tennessee - 11
Georgia - 23
Florida - 3
South Carolina - 1
North Carolina - 1
Virginia - 1
================================================================================
<Table>
Home Health Care Facts
1800's Home Health Care Begin October 1, 2000 Medicare allows profits
1965 Medicare started coverage 1999 Industry consolidation/closures
Home Health Care
1980's Technology goes to the home 1999 $36 Billion industry
1997 Balanced Budget Act changed the rules 1999 20,000 Providers treated 8M people
</Table>
================================================================================
What is Home Health Care Today?
"Medical care delivered to a homebound patient by licensed professionals
supervised by the patient's physician."
================================================================================
Amedisys is Positioned in the Largest Industry Segment...
<Table>
Nursing 70% STOCK PRICES
Infusion 14% 2-25-02
Respiratory 10% NURSING
DME 6% Amedisys $7.00
Gentiva $23.80
Odyssey $28.25
Source: Jeffries & Co. 2001 RESPIRATORY
Lincare $25.10
Apria $22.05
INFUSION
Option Care $13.10
</Table>
================================================================================
What Does Amedisys Offer?
<Table>
Care in These Areas...
Diabetes Cardiac Orthopedics
Cancer Respiratory Neurology
Wound Care Post-Surgical
Antibiotic Therapy Rehabilitation
Pain Mgt. Hydration Malnutrition
</Table>
================================================================================
Why is Amedisys a Healthy Investment?
o AMED is positioned for growth
o AMED is profitable
o AMED is partnered with industry leaders
================================================================================
Amedisys is Positioned for Growth
Growth Drivers
<Table>
Consolidation of Home Health Transition from Facility to Aging of America
Industry Non-Facility Care
</Table>
================================================================================
Amedisys is Positioned for Growth
o 26% decrease in companies since BBA 1997
o 30% of Medicare certified agencies are hospital based
o Hospitals lost the cost shifting benefit and are divesting
o Opportunities for acquisitions at reasonable costs
================================================================================
Amedisys is Positioned for Growth
Internal Growth Strategies
o Gain market share from agency attrition
o Increase referral base with superior DSM programs
o Build physician relationships with strong sales force
o Develop managed care business
External Growth Strategies
o Expand service area with quality acquisitions
o Valuations of agencies increasing but still attractive
================================================================================
Amedisys is Positioned for Growth
<Table>
<Caption>
Acquisition History
Alliance Home Health January 1998 Oklahoma
Precision Home Health April 1998 Louisiana
Columbia HCA November 1998 Southern States
Northwest Home Health October 2000 Georgia
Mid-Florida Home Health November 2000 Florida
Seton Home Health Services April 2001 Alabama
HealthCalls June 2001 South Carolina
Divested Non-Core Assets 1998 - 2001
</Table>
================================================================================
Amedisys is Positioned for Growth
o Health care costs are 14% of the GDP
o Home care is a cost effective alternative
o Millimann & Robertson - 56-64% of inpatient care is avoidable
o Home care reduces the length of hospital stays
o Payers encourage home care to preserve margins
o 90% of AARP members prefer to be treated at home
================================================================================
Amedisys is Positioned for Growth
<Table>
<Caption>
National Healthcare Expenditures as a Percentage of GDP
1980 8.8%
1990 12.0%
1993 13.4%
1996 13.3%
1997 13.2%
1998 13.0%
1999 13.0%
2000* 13.1%
2001* 13.4%
2002* 13.9%
2003* 14.3%
2004* 14.6%
2005* 14.9%
2006* 15.1%
2007* 15.3%
2008* 15.5%
2009* 15.7%
2010* 15.9%
Source: HCFA Online * Estimated
</Table>
================================================================================
Amedisys is Positioned for Growth
<Table>
<Caption>
Average Per Diem Cost Comparison
Inpatient Hospital $1,000
Skilled Nursing Facility $500
Home Health Care $90
Source: Jefferies & Co. 2001
</Table>
================================================================================
Amedisys is Positioned for Growth
<Table>
<Caption>
Home Healthcare Spending
1980 $2.4
1990 $12.6
1993 $21.9
1996 $33.6
1997 $34.5
1998 $33.5
1999 $33.1
2000* $36.6
2001* $41.3
2002* $46.6
2003* $51.4
2004* $56.4
2005* $61.1
2006* $66.0
2007* $71.2
2008* $76.2
2009* $81.5
2010* $87.0
Dollars in billions
* Projected Source: HCFA Online
</Table>
================================================================================
Amedisys is Positioned for Growth
<Table>
<Caption>
Pop. 65 yrs. and over. US, 1950 - 2030
1950 1960 1970 1980 1990 2000 2010 2020 2030
85+ 0.6 0.9 1.5 2.2 3.0 4.3 5.7 6.5 8.5
65+ 12.2 16.6 20.1 25.5 31.1 34.7 39.4 53.2 69.4
</Table>
<Table>
<Caption>
Source: Health, U.S. 1999, Health and Aging
Chartbook, U.S. Health and Human Services Dept. Current patients per 1,000 Population
Women Men
65-74 yrs. 27.6 18.2
75-84 yrs. 84.1 55.4
85+ 130.1 99.5
</Table>
================================================================================
Amedisys is Positioned for Growth
<Table>
<Caption>
Home Health Services Received By
Patients 65 Years of Age and Over
Nursing 85.3%
Homemaker 28.7%
Physical therapy 20.0%
Social services 10.9%
Medications 9.9%
Continuous home care 5.8%
Occupational therapy 4.8%
MD services 3.7%
Nutrition 3.4%
Other services 15.1%
Source, U.S. 1999, Health and Aging
Chartbook, U.S. Health and Human Services Dept.
</Table>
================================================================================
Amedisys is Profitable
o Episode costs are closely monitored
o Average episode costs are below episode payments
o Treatment protocols direct care, control costs
o Technology is creating more efficiency
================================================================================
Amedisys Is Profitable
<Table>
<Caption>
Prospective Payment System
Example: Patient with Diabetes
Fixed Rate $2,274
Illness Adj. 740
Wage Index (63)
Total Payment Per Episode $2,951
Net Profit $300
</Table>
================================================================================
Amedisys is Profitable
<Table>
<Caption>
Financial Performance
Revenues 1st Q 01 2nd Q 01 3rd Q 01 4th Q 01
Amounts in millions except Earnings per Share
Net Service Revenues $22.1 $27.2 $29.7 $31.1
Operating Income $0.1 $1.8 $2.6 $3.0
Net Income from Continuing $(0.4) $1.2 $2.0 $2.5
Operations (Loss) - Pre-Tax
EPS from Continuing Operations $(0.05) $0.15 $0.25 $0.31
(Loss) - Pre-Tax
</Table>
================================================================================
Amedisys is Profitable
<Table>
<Caption>
Financial Performance
Revenue 4th Q 01 4th Q 00 2001 2000
Amounts in millions except
Earnings Per Share
Net Service Revenue $31.1 $19.4 $110.2 $88.2
Operating Income $3.0 $(0.1) $7.5 $(2.6)
(Loss)
Net Income from $2.5 $(0.1) $5.3 $(4.3)
Continuing Operations -
Pre-Tax
EPS from Continuing $0.31 $(0.02) $0.66 $(1.00)
Operations - Pre-Tax
</Table>
================================================================================
Amedisys has a Profitable Growth Strategy
<Table>
<Caption>
Growth Strategy Going Forward
Capitalize on Exploit Trend to Grow with the
Industry Non-Facility Aging of America
Consolidation Based Care o Patients need more
o AMED will expand o AMED will provide a health care as they age
Markets with sale force viable solution to the o AMED provides home
o AMED will acquire increasing cost of health care - a patient's first
hospital based agencies care choice for care
</Table>
================================================================================
Amedisys is Partnered with Industry Leaders
Partners
in Wound Care
ConvaTec
Bristol-Myers Squibb divisions A Bristol-Myers Squibb Company
Hill-Rom Mead Johnson
A HILLENBRAND INDUSTRY Nutritionals
DU PONT
DuPont Pharmaceuticals Company
================================================================================
Amedisys is a Healthy Investment
Growth Driven by
Major Industry and
Demographic Trends
Profitable in the Partnered with
Prospective Payment Industry Leaders
System
Strengthening Increasing Visibility
Financial Position With Nasdaq Listing
And Stock Price
================================================================================
Put Amedisys in Your Portfolio
The Healthy Investment for the 21st Century